Biogen Idec / Genzyme / Cold Spring Harbor Laboratory / Isis Pharmaceuticals Inc. / /
Continent
Europe / /
Country
Japan / United States / Canada / /
Event
FDA Phase / Business Partnership / Product Issues / /
Facility
Columbia University Medical Center / Children's Hospital of Philadelphia Infant Test / University of Massachusetts Medical School / Nemours Children's Hospital / /
IndustryTerm
therapies for neurological disorders / treatment of neurological and neuromuscular disorders / study site / antisense technology / /
MedicalCondition
progressive muscle weakness / neurological disorders / neurological and neuromuscular disorders / pneumonia / common fatal genetic disease / cancer / spinal muscular atrophy / disease / severe and rare diseases / myotonic dystrophy / severe genetic disease / diseases / /
OperatingSystem
Isis / /
Organization
Muscular Dystrophy Association / Nemours Children's Hospital / United States Food and Drug Administration / Families of SMA / SMA Foundation / Columbia University Medical Center / Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders / American Academy / University of Massachusetts Medical School / 66th American Academy of Neurology / /
Person
Claudia Chiriboga / C. Frank Bennett / Richard Finkel / /
Position
associate professor of clinical neurology and clinical pediatrics / senior vice president of research / chief / division of neurology / /
http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-newsArtic